Dare Bioscience, Inc. — Director's Dealing 2015

Dec 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-09-04

Reporting Person: Senderowicz Adrian (SVP, Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-04	Incentive Stock Option (right to buy)	$4.21	A	135000	Acquired	2024-09-03	Common Stock (135000)	Direct

Footnotes

F1: The shares underlying this option vest as to 1/4th of the shares on the first anniversary of September 4, 2015 and as to an additional 1/48th of the original number of shares at the end of each month of continuous service thereafter.